On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...

A baby born with a rare genetic disorder has taken his first steps after receiving a groundbreaking, personalized gene ...

The U.S. Food and Drug Administration says it's aware of “do-it-yourself” kits for producing gene therapies for ...

The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Kavita Mehta suffers from beta thalassaemia, a genetic condition preventing her body from producing sufficient haemoglobin ...

The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ...

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...

A 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment was released from the hospital this week.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...

He was cast as a real-life Dr Frankenstein, a scientist whose ego had led him to tamper with human life. After more than a hundred Chinese scientists issued a statement condemning his experiment, ...